CDP COPT Defense posts narrow Q4 2025 EPS miss shares rise modestly as investor sentiment holds steady Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside DMAC DiaMedica posts narrower than expected Q4 2025 loss shares fall 418 in todays trading session Adidas Equity Performance and Running Category Strategy Analysis London Marathon Catalyst SCEM SCE Trust latest quarterly earnings metrics remain undisclosed as investors await full official performance disclosures Williams Companies WMB Valuation Assessment Following 5 Quarterly Dividend Hike and Recent Share Price Momentum